Human ornithine transcarbamylase. Purification and characterization of the enzyme from normal liver and the liver of a Reye's syndrome patient.
Ornithine transcarbamylase was purified and characterized from normal human liver. The properties of this enzyme were compared to those of ornithine transcarbamylase purified from the liver of a patient with Reye's syndrome. The enzyme isolated from both sources appeared virtually identical for a variety of biochemical characteristics. The native molecular weight of ornithine transcarbamylase is 110,000 as determined by gel filtration. Electrophoresis of the enzyme, dissociated by sodium dodecyl sulfate, indicated that the enzyme exists as a trimer of identical or similar subunits of 36,500 daltons. Ornithine transcarbamylase from normal liver has an isoelectric point of 7.95, and the value for the enzyme from the Reye's syndrome liver was 8.05. No evidence of multiple species was found during the purification or subsequent characterization of the enzyme. The enzyme exhibited normal Michaelia-Menten kinetics, and the apparent Michaelis constants for L-ornithine and carbamyl phosphate are 0.20 mM and 0.09 mM, respectively. Inhibitor studies established the structural requirements for L-ornithine antagonists. L-Norvaline is the best competitive inhibitor of the enzyme with respect to L-ornithine. This study indicated that the reduced level of ornithine transcarbamylase activity commonly observed in Reye's syndrome is not necessarily due to structural or functional alterations of the enzyme.
D005260:Female; D006801:Humans; D007223:Infant; D007525:Isoelectric Focusing; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D008970:Molecular Weight; D009954:Ornithine Carbamoyltransferase / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000378:metabolism*; D012202:Reye Syndrome / Q000201:enzymology*
D009954:Ornithine Carbamoyltransferase